ExodusPoint Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Sell |
18,217
-179,318
| -91% | -$3.13M | ﹤0.01% | 1169 |
|
|
2025
Q1 | $2.49M | Buy |
197,535
+172,907
| +702% | +$2.18M | 0.02% | 581 |
|
|
2024
Q4 | $260K | Buy |
+24,628
| New | +$260K | ﹤0.01% | 1203 |
|
|
2024
Q1 | – | Sell |
-38,022
| Closed | -$208K | – | 1813 |
|
|
2023
Q4 | $208K | Buy |
38,022
+26,992
| +245% | +$148K | ﹤0.01% | 1200 |
|
|
2023
Q3 | $42K | Buy |
+11,030
| New | +$42K | ﹤0.01% | 1570 |
|
|
2022
Q1 | – | Sell |
-19,148
| Closed | -$128K | – | 2577 |
|
|
2021
Q4 | $128K | Buy |
+19,148
| New | +$128K | ﹤0.01% | 1872 |
|
|
2021
Q1 | – | Sell |
-20,882
| Closed | -$968K | – | 2500 |
|
|
2020
Q4 | $968K | Buy |
+20,882
| New | +$968K | 0.01% | 818 |
|